Table 1 of
Altay, Mol Vis 2020; 26:661-669.
Table 1. Baseline characteristics of all subjects.
| Baseline characteristics | No EMD | EMD | p-value |
|---|---|---|---|
| Number of patients, n | 912 | 608 | |
| Female sex, n (%) | 440 (48.2%) | 454 (74.7%) | p<0.001* |
| Age (years), mean ±SD | 71.20±10.17 | 74.51±8.02 | p<0.001 * |
| AMD status | p<0.001* | ||
| No AMD, n (%) | 623 (68.3%) | 134 (22.0%) | |
| Early/intermediate AMD, n (%) | 158 (17.3%) | 188 (30.9%) | |
| Late AMD, n (%) | 131 (14.4%) | 286 (47.0%) | |
| C3d/C3 Ratio (ln), mean ±SD | 1.41±0.40 | 1.51±0.40 | p<0.001† |
| Ever smoked, n (%) | 482 (52.85%) | 257 (42.27%) | p<0.001* |
| Hypertension, n (%) | 299 (32.79%) | 204 (33.55%) | p=0.220* |
| Cardiovascular diseases, n (%) | 154 (16.89%) | 97 (15.95) | p=0.525* |
| BMI ≥25, n (%) | 497 (54.50%) | 289 (47.53%) | p=0.023* |
| Diabetes, n (%) | 77 (8.44%) | 47 (7.73%) | p=0.561* |
| Allergy, n (%) | 177 (19.41%) | 111 (18.26%) | p=0.484* |
| Sunlight exposure ≥8h, n (%) | 82 (8.99%) | 96 (15.79%) | p<0.001* |
| Total cholesterol (mmol/l), mean ±SD | 5.71±1.22 | 5.91±1.16 | p=0.003† |
| HDL cholesterol (mmol/l), mean ±SD | 1.42±0.37 | 1.56±0.37 | p<0.001† |
| Triglyceride (mmol/l), mean ±SD | 1.96±0.99 | 1.72±0.89 | p<0.001† |